Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Dain

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Maturitas|September 1, 1995
Efficacy and tolerance of Menorest compared to Premarin in the treatment of postmenopausal women. A randomised, multicentre, double-blind, double-dummy studyJ W Studd, K McCarthy, D Zamblera, et al.
Diabetes, Obesity & Metabolism|June 25, 2014
Modulation of insulin dose titration using a hypoglycaemia-sensitive algorithm: insulin glargine versus neutral protamine Hagedorn insulin in insulin-naïve people with type 2 diabetesP D Home, G B Bolli, C Mathieu, et al.
Diabetes, Obesity & Metabolism|November 1, 2014
Comparison of insulin glargine and liraglutide added to oral agents in patients with poorly controlled type 2 diabetesD D'Alessio, H-U Häring, B Charbonnel, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Maturitas|September 1, 1995
Efficacy and tolerance of Menorest compared to Premarin in the treatment of postmenopausal women. A randomised, multicentre, double-blind, double-dummy studyJ W Studd, K McCarthy, D Zamblera, et al.
Diabetes, Obesity & Metabolism|June 25, 2014
Modulation of insulin dose titration using a hypoglycaemia-sensitive algorithm: insulin glargine versus neutral protamine Hagedorn insulin in insulin-naïve people with type 2 diabetesP D Home, G B Bolli, C Mathieu, et al.
Diabetes, Obesity & Metabolism|November 1, 2014
Comparison of insulin glargine and liraglutide added to oral agents in patients with poorly controlled type 2 diabetesD D'Alessio, H-U Häring, B Charbonnel, et al.
Pageof 3